As kids across the US returned to school this fall, cases of walking pneumonia, caused by mycoplasma pneumoniae bacteria, have been on the rise. This respiratory illness, often referred to as walking pneumonia due to its milder symptoms compared to other lung infections, can be tricky to diagnose and expensive to test for.
Doctors may choose different antibiotics to treat walking pneumonia on a case-by-case basis. While macrolide antibiotics like azithromycin are commonly recommended, there isn't clear data on which medication works best. In practice, doctors rely on their experience, local disease trends, and patient history to determine the most appropriate treatment.
Despite its milder nature, walking pneumonia can still be burdensome for families as it can last for several weeks. In rare cases, it can lead to complications such as brain swelling, kidney issues, and difficulty breathing. People with lung issues and weakened immune systems may be at higher risk of hospitalization.
Recent CDC data suggests a surge in walking pneumonia infections, with outbreaks even among young adults in dorms. The illness has been more common among school-aged children historically, but this year has seen an increase in cases among toddlers as well.
While walking pneumonia may not be as severe as other seasonal illnesses like the flu or COVID-19, it is still important to be aware of the symptoms – persistent cough, fever, and fatigue. If symptoms persist or worsen, it is recommended to seek medical attention for proper diagnosis and treatment.
In conclusion, the rise in walking pneumonia infections highlights the importance of staying vigilant and seeking medical care when necessary, especially during the fall and winter months when respiratory illnesses are more prevalent.